![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 28, 2000 2:40:56 AM
IVRT,
Just got your message. Dr. Frudakis' presentation was very informative, however, we do not have an audio, video, or transcript of the event.
In answering your question, DNAPrint does not intend to market its own products, but rather partner with larger companies that have that ability. Also, we are not asking the doctor to substitute their drug choice for another, but to run a test before prescribing the drug to make sure that it does not cause serious side-effects. We feel that if a test is available that can determine this information, then the doctor is morally obligated to perform that test.
Regards,
Craig Hall
----- Original Message -----
From: CMAACCESS
To: Richard Craig Hall
Sent: Friday, December 01, 2000 4:23 PM
Subject: Fw: Question
Craig, I sent this to Dr. Tony and have not received a response. Can you please relay this message to him for an answer? Thanks and I hope you had a great Thanksgiving holiday too? Also, one finally note Craig, will you audio/videotape or transcript any/all of the open house tomorrow? I will not make the open house, but I am genuinely interested in the contents. Thanks!
----- Original Message -----
From: CMAACCESS
To: tfrudakis@dnaprint.com
Sent: Friday, November 24, 2000 1:06 PM
Subject: Question
Dr. Frudakis, what do you think will be your greatest tool in convincing Doctors to initially allow a platform software program, such as DNAP's to recommend, and subsequently having the doctor actually substitute his/her preferred drug choice, with DNAP's drug choice? Thanks for your answer!
IVRT
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM